Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman–Sacks endocarditis: a case for antibiotic prophylaxis?

By Armstrong David   Wright Stephen   McVeigh Claire   Finch Michael  

Clinical Rheumatology, Vol. 25, Iss. 4, 2006-07 ,pp. : 583-584

Springer Publishing Company

Access to resources Recommend Favorite

Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus

By AlE’ed Ashwaq   AlSonbul Abdullah   Al-Mayouf Sulaiman  

Rheumatology International, Vol. 34, Iss. 4, 2014-04 ,pp. : 529-533

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Type 1 Diabetes with Anti-CD3 Monoclonal Antibody

By Glandt Mariela   Hagopian William   Herold Kevan C.  

Reviews in Endocrine and Metabolic Disorders, Vol. 4, Iss. 4, 2003-12 ,pp. : 361-368

Springer Publishing Company

Access to resources Recommend Favorite

Efalizumab, a Human Monoclonal Anti-CD11a Antibody, in the Treatment of Moderate to Severe Crohn’s Disease: An Open-Label Pilot Study

By James Dustin   Seo Da   Chen Jiajing   Vemulapalli Caroline   Stone Christian  

Digestive Diseases and Sciences, Vol. 56, Iss. 6, 2011-06 ,pp. : 1806-1810

Springer Publishing Company

Access to resources Recommend Favorite

Intravenous cyclophosphamide for lupus nephritis in Thai children

By Vachvanichsanong P   Dissaneewate P   Winn T  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 5, 2004-10 ,pp. : 339-342

Informa Healthcare

Access to resources Recommend Favorite